PreveCeutical Medical Inc (PRVCF)

[JellyDonut]

News! $PRVCF NetworkNewsWire Announces Publication on Unique New Paradigms in Cannabinoid Drug Delivery

NEW YORK, Feb. 22, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring PreveCeutical Medical Inc. (OTCQB:PRVCF) (CSE:PREV) (FSE:18H), a client of NNW and health sciences company that develops innovative preventive therapies utilizing organic and nature identical products.

To view the full publication, titled “A New Breakthrough in Cannabinoid Drug Delivery,” visit: http://nnw.fm/9l2Zl

In a unique and potentially transformative drug delivery technique, PreveCeutical Medical Inc. (CSE:PREV) (OTCQB:PRVCF) (FSE:18H) is engineering the world’s first nose-to-brain drug delivery platform. In research and development for over seven years by PreveCeutical’s Chief Research Officer, Dr. Harendra Parekh, Ph.D., the company’s novel Sol-gel technology is designed for enhanced efficacy, targeted delivery and superior time release of cannabinoid (CBD) based medications. Bypassing the blood brain barrier, this nasal spray formulation rapidly gels upon contact with mucosal tissue to effectuate targeted drug delivery directly to the brain. PreveCeutical’s platform circumvents the blood stream and allows specific doses to reach specific targets without the filtering and metabolism that occur in the liver.